Your browser doesn't support javascript.
loading
DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults.
Ferris, Margaret A; Smith, Amanda M; Heath, Sharon E; Duncavage, Eric J; Oberley, Matthew; Freyer, David; Wynn, Robert; Douzgou, Sofia; Maris, John M; Reilly, Anne F; Wu, Melinda D; Choo, Florence; Fiets, Roel B; Koene, Saskia; Spencer, David H; Miller, Christopher A; Shinawi, Marwan; Ley, Timothy J.
Afiliación
  • Ferris MA; Department of Pediatrics.
  • Smith AM; Department of Medicine, and.
  • Heath SE; Department of Medicine, and.
  • Duncavage EJ; Department of Pathology and Immunology, Washington University, St Louis, MO.
  • Oberley M; Caris Life Sciences, Phoenix, AZ.
  • Freyer D; Children's Hospital Los Angeles, Los Angeles, CA.
  • Wynn R; Paediatric Haematology and Bone Marrow Transplant (BMT), Royal Manchester Children's Hospital, Manchester, United Kingdom.
  • Douzgou S; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Maris JM; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.
  • Reilly AF; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Wu MD; Children's Hospital of Philadelphia, Philadelphia, PA and.
  • Choo F; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Fiets RB; Children's Hospital of Philadelphia, Philadelphia, PA and.
  • Koene S; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Spencer DH; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Oregon Health & Science University, Portland, OR.
  • Miller CA; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Oregon Health & Science University, Portland, OR.
  • Shinawi M; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands; and.
  • Ley TJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Blood ; 139(3): 461-464, 2022 01 20.
Article en En | MEDLINE | ID: mdl-34788385
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / ADN Metiltransferasa 3A / Mutación Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / ADN Metiltransferasa 3A / Mutación Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article